«Нормальные» величины CAVI для российской популяции Рогоза А.Н. ОТДЕЛ НОВЫХ МЕТОДОВ ДИАГНОСТИКИ ФГБУ РКНПК МЗ РФ Российский национальный конгресс кардиологов,

Slides:



Advertisements
Similar presentations
Cardiovascular Risk Assessment
Advertisements

Università degli Studi di Roma Tor Vergata
1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.
Ethnic differences in risks and explanations for the cardiometabolic syndrome in the UK Nish Chaturvedi Professor of Clinical Epidemiology Imperial College.
Morteza Naghavi, M.D. Society for Heart Attack Prevention and Eradication (SHAPE) Detection and Treatment of Asymptomatic Atherosclerosis for Primary Prevention.
CONTROLLING YOUR RISK FACTORS Taking the Steps to a Healthy Heart.
U.S. Dept of Health and Human Services. National High Blood Pressure Education Program. Seventh Report of Joint National Committee on Prevention, Detection,
Task Force on Diabetes and CVD (ESC and EASD) European Heart Journal 2007;28:
Chapter 1: CKD in the General Population 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
1 Prediabetes Comorbidities and Complications. 2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep.
PAD A Call to Action. PAD: A Call to Action - What is peripheral arterial disease (PAD)? and why is it so dangerous? - Diagnosing PAD in the primary care.
Factors associated with prediabetes in adult children of patients with premature coronary heart disease; the study of families of patients with premature.
Etiology Primary hypertension 95% of all cases Secondary hypertension – 5% of all cases – Chronic renal disease – most common White coat hypertension –
Presenter Disclosure Information Diane Bild, MD, MPH Screening for Subclinical Atherosclerosis as a Strategy for CVD Prevention FINANCIAL DISCLOSURE: None.
Assessment of Target Organ Damage: Established and Novel Methods Christian Delles BHF Glasgow Cardiovascular Research Centre Institute of Cardiovascular.
Specific guidelines on the use of arterial measurements Jiguang WANG, MD, PhD Professor of Cardiovascular Medicine The Shanghai Institute of Hypertension,
Morteza Naghavi, M.D. Founder Society for Heart Attack Prevention and Eradication (SHAPE) SHAPE Guidelines Prevention of Fatal Cardiovascular Events (Heart.
Surrogate Measures of Atherosclerosis and Implications for Evaluating Cardiovascular Risk Nathan D. Wong, Ph.D., F.A.C.C. Associate Professor and Director.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Cardiovascular Disease in Women Module III: Risk Assessment Tool.
LIFESTYLE MODIFICATIONS FOR PREVENTING HEART DISEASE [e.g. HEART ATTACKS] [ primary prevention of coronary artery disease ] DR S. SAHAI MD [Med.], DM [Card]
Health Screening. Should you go for health screening? Health screening helps to discover if a person is suffering from a particular disease or condition,
METABOLIC Syndrome: a Global Perspective
Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.
SERUM VISFATIN CONCENTRATION IS ASSOCIATED WITH AN ATHEROGENIC METABOLIC PROFILE T.D. Filippatos 1, A. Liontos 1, F. Barkas 1, E. Klouras 1, V. Tsimihodimos.
The National Kidney Foundation’s Kidney Early Evaluation Program TM “The Greater New York Experience” Ellen H. Yoshiuchi, MPS Division Program Director.
Atherosclerosis Part 1 Atherosclerosis The general term for hardening of the arteries The most prevalent form of atherosclerosis is characterized by the.
FAME HTN Mohsen. Epidemiology and stuff  About 1/3 of middle aged patients have hypertension  About ½ of elderly patients have hypertension.  Responsible.
0CTOBER 2010 An Approach for Sub-Saharan Africa. Dr. Linda Hawker, MD, CCFP General Practice Kelowna BC Canada.
 Update on Hypertension Troy L. Randle, DO, FACC, FACOI.
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
Blood pressure control in primary health care WORKSHOP
10 Points to Remember on the Assessment of Cardiovascular RiskAssessment of Cardiovascular Risk Summary Prepared by Melvyn Rubenfire, MD.
Organizational criteria for Metabolic Syndrome National Cholesterol Education Program Adult Treatment Panel III World Health OrganizationAmerican Association.
1 Cecil Medicine Section VIII Chapter 66 Arterial Hypertension Prof. Shen-Jiang Hu.
BASIC analysis of --- Stress/overwork and cardiovascular disease data Sino-Japanese cooperation project by Mile Xiu.
Diabetes National Diabetes Control Programme
High level of low density lipoprotein cholesterol in adult children of patients with premature coronary heart disease: relation to own and parental characteristics.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
RISK STRATIFICATION. Established by the CACR in Sept National Guidelines Committee The committee acknowledged the support of the Canadian Cardiovascular.
Arterial Hypertension
Hypertension BP ≥140/90 (WHO/ISH,1993) Isolated systolic hypertension: BP syst ≥ 140 mm Hg, BP diast. < 90 mm Hg.
Lesotho STEPS Survey 2012 Fact Sheet John Nkonyana Director Disease Control.
Section III. Assessment of Overall Cardiovascular Risk in Hypertensive Patients 2015 Canadian Hypertension Education Program Recommendations.
Morteza Naghavi, M.D. Society for Heart Attack Prevention and Eradication (SHAPE) Houston, TX Screening for Early Detection and Prevention of Heart Attack.
Impact of Diabetes on Cardiovascular Risk C.Richard Conti M.D. MACC Oct 16,2004 GWICC Beijing, PRC.
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
Treatment of Hypertension in Adults With Diabetes DR AMAL HARFOUSH.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for.
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Plasma triglycerides and type III hyperlipidemia.
Powered by Infomedica Infomedica Conference Coverage* of 26 th European Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13,
Figure 1.1 Prevalence of CKD by stage among NHANES participants,
From ESH 2016 | LB 3: Davide Agnoletti, MD
Coronary Heart Disease
Non-metabolic syndrome mean (DS) Metabolic syndrome mean (DS)
Phenotype vs. Genotype: Defining Severe Familial Hypercholesterolemia
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
Six-month–adjusted survival after aortic valve replacement (AVR) for severe aortic stenosis (AS) stratified by procedure and preoperative ejection fraction.
برنامه غربالگری و بیماریابی بیماری های قلبی عروقی و عوامل خطر آن در استان فارس معاونت بهداشتی دانشگاه علوم پزشکی شیراز واحد غیر واگیر برنامه قلب و عروق.
Mario F. Rubin, MD, Sylvia E. Rosas, MD, Julio A
Chapter 2: Pharmacological cholesterol-lowering treatment in adults
Section I: RAS manipulation C. Update on clinical trials in CAD
Volume 79, Pages S9-S13 (April 2011)
Level of risk factor control in the overall sample and by gender
Cardiovascular Disease in Women Module III: Risk Assessment Tool
Hazard ratios, with 95% confidence intervals as floating absolute risks, as estimate of association between category of updated mean haemoglobin A1c concentration.
Multivariable-adjusted HRs and 95% CIs for outcomes for waist circumference. Multivariable-adjusted HRs and 95% CIs for outcomes for waist circumference.
Presentation transcript:

«Нормальные» величины CAVI для российской популяции Рогоза А.Н. ОТДЕЛ НОВЫХ МЕТОДОВ ДИАГНОСТИКИ ФГБУ РКНПК МЗ РФ Российский национальный конгресс кардиологов, Казань 2014

Жесткость артерий

Expert consensus document on arterial stiffness: methodological issues and clinical applications Согласованное мнение экспертов ESC по вопросу артериальной ригидности: методические аспекты и клинические применения European Heart Journal (21):

В настоящее время максимальное распространение получила методика измерения СПВ при расположении сфигмодатчиков над проекциями сонной и бедренной (в районе пупартовой связки) артерий. Соответственно для этой использоваться обозначение СБ СПВ. Для определения СБ СПВ по классической методике необходимо одновременно зарегистрировать две качественные сфигмограммы в указанных выше точках и определить задержку dt между моментами появления пульсаций в исследуемых точках сосудистого русла. Нейрософт, Иваново

Согласованное мнение экспертов ESC по вопросу артериальной ригидности: методические аспекты и клинические применения (2006) Итоговое заключение. Измерения Жесткости аорты и центрального давления должны рассматриваться как рекомендованные тесты для оценки с-с рисков, причем особенно у тех пациентов, где при обычном обследовании не выявлены поражения органов-мишеней.

ESH 2007 ВНОК 2008 Исследования, рекомендуемые дополнительно при обследовании больных с АГ содержание в сыворотке крови мочевой кислоты, калия; ЭхоКГ; определение МАУ; исследование глазного дна; УЗИ почек и надпочечников; УЗИ брахиоцефальных и почечных артерий рентгенография органов грудной клетки; СМАД и СКАД; определение лодыжечно-плечевого индекса; определение скорости пульсовой волны (показатель ригидности магистральных артерий); пероральный тест толерантности к глюкозе - при уровне глюкозы в плазме крови > 5,6 ммоль/л (100 мг/дл); количественная оценка протеинурии (если диагностические полоски дают положительный результат);

СПВ с учетом возраста и уровня АД!!!!!

Февраль 2012 г. СПВ = 10 м/с

Современные приборы для массового определения СПВ  ABI – Ankle-Brachial Index  PWV – Pulse Wave Velocity (Normally PWV is lower than 9m/s at the aorta.) (An index below 0.9 suggests possible occlusion.) Femoral Pulse Carotid Pulse PCG ECG Source: “Aortic Pulse Wave Velocity Method; Usefulness ハ for Diagnosis of Atherosclerosis and Observation of its Progress” Supervision: Motoharu Hasagawa Publisher: Medical Electro Time Femoral Pulse Carotid Pulse PCG ECG

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults Developed in Collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance

Recommendation for Specific Measures of Arterial Stiffness Measures of arterial stiffness outside of research settings are not recommended for cardiovascular risk assessment in asymptomatic adults. I IIaIIbIII

The writing committee felt that: A.Measurement protocols must be well standardized (Expert Consensus, 2012) B.Quality control procedures must be established. (VS1000, VS1500 – YES) C.Reproducibility is a problem, as method is operator dependent. (VS1000, VS1500 – NO) D.Riskdefining thresholds must be identified. (Real Problem for CAVI)

K. Shirai, N. Hiruta et al, J Atheroscler Thromb, 2011; 18:

Показ атель  20 лет лет лет лет лет лет >70 лет CAVI6,7  0,76 7,2  0,61 7,4  0,63 7,55  0,7 8,0  0,67 8,5  0,64 9,8  1,51 Таблица 2. Показатели объемной сфигмографии в зависимости от возраста (M  SD )

Показатель  20 лет лет лет лет лет лет >70 лет CAVI6,7  0,76 7,2  0,61 7,4  0,63 7,55  0,7 8,0  0,67 8,5  0,64 9,8  1,51

Признаки повышенной жесткости стенки магистральных артерий «Возрастные Пороговые» значения До 30 лет лет 8.3 Выше

Ivanovo St. Petersburg Vladikavkaz Tomsk Tyumen participants “ ЭССЕ-РФ " Cardiology Research Center, Moscow, Russian Federation 6 November 2012 – 1548 report of VaSera VS-1500 collected in

Япония –2672 (23%) Россия 2000 – 1360 – 83 (6%)

Medical Education & Information – for all Media, all Disciplines, from all over the World Powered by 2013 ESH/ESC Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) - J Hypertension 2013;31: Factors—other than office BP—influencing prognosis (used for stratification of total CV risk in prev. slide) BMI, body mass index; BP, blood pressure; BSA, body surface area; CABG, coronary artery bypass graft; CHD, coronary heart disease; CKD, chronic kidney disease; CV, cardiovascular; CVD, cardiovascular disease; EF, ejection fraction; eGFR, estimated glomerular filtration rate; HbA 1c, glycated haemoglobin; IMT, intima-media thickness; LVH, left ventricular hypertrophy; LVM, left ventricular mass; PCI, percutaneous coronary intervention; PWV, pulse wave velocity. a Risk maximal for concentric LVH: increased LVM index with a wall thickness/radius ratio of Risk factors Male sex Age (men ≥55 years; women ≥65 years) Smoking Dyslipidaemia - Total cholesterol >4.9 mmol/L (190 mg/dL), and/or - Low-density lipoprotein cholesterol >3.0 mmol/L (115 mg/dL), and/or - High-density lipoprotein cholesterol: men <1.0 mmol/L (40 mg/dL), women <1.2 mmol/L (46 mg/dL), and/or - Triglycerides >1.7 mmol/L (150 mg/dL) Fasting plasma glucose 5.6–6.9 mmol/L (102–125 mg/dL) Abnormal glucose tolerance test Obesity [BMI ≥30 kg/m 2 (height 2 )] Abdominal obesity (waist circumference: men ≥102 cm; women ≥88 cm) (in Caucasians) Family history of premature CVD (men aged <55 years; women aged <65 years Diabetes Mellitus Fasting plasma glucose ≥7.0 mmol/L (126 mg/dL) on two repeated measurements, and/or HbA 1c >7% (53 mmol/mol), and/or Post-load plasma glucose >11.0 mmol/L (198 mg/dL) Asymptomatic organ damage Pulse pressure (in the elderly) ≥60 mmHg Electrocardiographic LVH (Sokolow–Lyon index >3.5 mV; RaVL >1.1 mV; Cornell voltage duration product >244 mV*ms), or Echocardiographic LVH [LVM index: men >115 g/m 2 ; women >95 g/m 2 (BSA)] a Carotid wall thickening (IMT >0.9 mm) or plaque Carotid-femoral PWV >10 m/s Ankle/brachial BP index <0.9 CKD with eGFR 30–60 ml/min/1.73 m 2 (BSA) Microalbuminuria (30–300 mg/24 h), or albumin–creatinine ratio (30–300 mg/g; 3.4–34 mg/mmol) (preferentially on morning spot urine) Established CV or renal disease Cerebrovascular disease: ischaemic stroke; cerebral haemorrhage; transient ischaemic attack CHD: myocardial infarction; angina; myocardial revascularization with PCI or CABG Heart failure, including heart failure with preserved EF Symptomatic lower extremities peripheral artery disease CKD with eGFR 300 mg/24 h) Advanced retinopathy: haemorrhages or exudates, papilloedema

233 women (age – 50,8±5,4), 79 men (age – 49,8±4,2) with low and moderate cardiovascular risk by the SCORE scale, who has been seeking medical help to local Moscow outpatient hospital and agreed to participate in the study. All patients have been investigated by color duplex ultrasound imaging of carotid arteries and by Vascular Screening System VaSera VS-1000 to obtain CAVI. CAVI и атеросклероз СА

CAVI and carotid atherosclerosis Intima-Medial Thickness (IMT) ultrasonography (cutoff value 0.9 mm) Plaque-Score: PS=a+b+c+d. S1-S4 CIMT>0.9mm Plaque women men

CAVI и атеросклероз СА Area under the ROC curve = 0,699 Confidence interval = 0,640 to 0,754 CAVI= 7,0 * Sens. 67,4% ; Spec. 65,1% CAVI= 9.0 Sens. 10% ; Spec. 98% CAVI выше 7.0 может рассматриваться в качестве индикатора каротидного атеросклероза

CAVI: age dependent “nornal” values and “standard” “riskdefining thresholds” (cut-off value) K. Shirai, N. Hiruta et al, J Atheroscler Thromb, 2011; 18:

“ESSE-RF" NEW questions: What is the best index of the stiffness: cfPWV, aortic PWV, “traditional” CAVI, kCAVI, cfCAVI, aortic CAVI (AoVI), …….. ? Aortic CAVI (AoVI)? caPWV ckneePWV cfemoralPWV (aortic PWV) cfPWV CAVI kCAVI AoVI cfCAVI Cut-off value for cfCAVI IF Cut-off value for cf PWV=10 m/c cfCAVI - 1.9*PWV -6.5 = = 13.5